(Q40887973)

24 September 2017

1 reference

title

HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies (English)

1 reference

24 September 2017

Valerius T

1

1 reference

24 September 2017

Elsässer D

2

1 reference

24 September 2017

Repp R

3

1 reference

24 September 2017

Van de Winkel JG

4

1 reference

24 September 2017

Gramatzki M

5

1 reference

24 September 2017

Glennie M

6

1 reference

24 September 2017

1 July 1997

1 reference

24 September 2017

1 reference

24 September 2017

26

1 reference

24 September 2017

3-4

1 reference

24 September 2017

261-269

1 reference

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

24 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Direct killing of interleukin-2-transfected tumor cells by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Cytotoxicity mediated by human Fc receptors for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

Bispecific monoclonal antibody therapy of B-cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

"Diabodies": small bivalent and bispecific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199709051775

10.3109/10428199709051775

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference